1. Market Research
  2. > Healthcare Market Trends
HIV Diagnosis Market by Test Type, Viral Load, CD4 Count, Early Infant, Viral Identification, Product, End User - Global Forecast to 2021

HIV Diagnosis Market: Global Forecast until 2021

  • March 2017
  • 139 pages
  • ID: 4767737
In this report:
THE WESTERN BLOT TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR A SHARE OF ##.##% OF THE HIV-## ANTIBODY CONFIRMATORY TESTS MARKET IN 2016; IT IS EXPECTED TO GROW AT CAGR OF ##.##% TO REACH USD ##.## MILLION BY 2021.
THIS IS EVIDENT BY ITS INCREASING R&D EXPENDITURE FROM ##.##% OF TOTAL REVENUE IN 2014 TO ##.##% IN 2015.

Summary

Table of Contents

Search Inside

The HIV diagnosis market is estimated to grow ~$3.9B by 2021 from ~$2.3B in 2016, at a compound annual growth rate (CAGR) of 10.50 percent from 2016 to 2021. The overall HIV diagnosis market is divided established on the basis of product, test type, final user, and area. On the basis of product, the sector is divided into consumables (assays, kits, reagents, and other consumables), instruments, and software & services. The consumable segment is projected to register the highest compound annual growth rate (CAGR) during the outlook period. The frequent and repetitive purchase of consumables by laboratories and hospitals, increasing prevalence of HIV/AIDS, and growing initiatives from governments to fight HIV/AIDS are some of the main factors driving the consumables market.

On the basis of test type, the sector is divided into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. The antibody tests segment is intended to account for the most important share of the HIV diagnosis market in 2016. These tests are widely adopted to screening and confirmation of HIV antibodies. Furthermore, rising prevalence of HIV/AIDS, growing awareness about HIV, rising blood donations and transfusions, and advancements in technology are forecast to steer the rise of this market.

On the basis of end user, the HIV diagnosis market is detached into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is forecasted to account for the biggest share of HIV diagnosis market in 2016. Growing awareness about HIV/AIDS and advancements in PoC instruments and consumables are main drivers for this end-user segment.

Geographically, North America (NA) controls the overall HIV diagnosis market. The government initiatives and funding in order to rise HIV diagnosis procedures and create appreciation amongst the pollution and rising number of blood transfusions are growing the industry demand for HIV diagnosis products in North America continent.

The key factors providing to the rise of the overall HIV diagnosis market contain the rising prevalence of HIV/AIDS global, growing number of blood transfusions and blood donations, profits provided by point-of-care instruments & kits, and rising government initiatives. On the other hand, the high cost of NAT and lack of mandates for NAT in developing countries are the main factors restraining the increase of this market. The huge growth potential in the Asian area offers alternatives for competitors in the HIV diagnosis market.

The main players in the HIV diagnosis market are Siemens (SIA), Roche Diagnostics, Abbott Laboratories (NYSE:ABT), Danaher (NYSE:DHR), Thermo-Fisher Scientific Inc., Merck KGaA (MKGA), Becton Dickinson (NYSE:BDX), Becton, Dickinson and Company (BD) (NYSE:BDX), Hologic, Incorporated, Alere Inc., and Bio-Rad Laboratories.

Segment Research

Apart from comprehensive geographic and product review and sizing of market, the study also offers a competitive analysis that includes the increase strategies approved by sector actors over the last three years. Additionally, the corporation reviews include the product types, advancements, and strategies approved by actors to maintain and rise their companies in the industry.

Why Purchasing This Study Can Help You:

This business report will allow both established firms as well as new entrants/smaller companies to measure the pulse of the sector, which in turn will facilitate these companies collect greater segment market share. Firms obtaining the analysis can use any one or an aggregation of the below-mentioned five strategies (sector entry, product improvement/innovative projects, sector development, business diversification, and opposing assessment) for strengthening their market shares.

This study furnishes highlights on the following points:

- Business entry: Exhaustive information on the product portfolios of the top actors in the HIV diagnosis market. The report analyses the HIV diagnosis market by product, test type, end-user, and area.

- Product improvement/Innovative products: In-depth understanding on the next technologies, Research&development activities, and recent product launches in the HIV diagnosis market

- Opposing assessment: In-depth assessment of the market strategies, geographic and industry segments, and product review of the main players in the HIV diagnosis market

- Industry development: Highlighted information about emerging sectors. This industry report examines the sector for HIV diagnosis across geographies

- Industry diversification: Complete information about recent products, untapped areas, recent evolutions, and market investments in the HIV diagnosis market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Molecular Diagnostics Market by Application, Oncology, Genetics, Microbiology, Technology, End User, Product & Service - Forecast to 2021

Molecular Diagnostics Market: Forecast until 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global molecular diagnostics market is projected to reach USD 10.12 billion by 2021 from USD 6.54 billion in 2016, at a CAGR of 9.1% from 2016 to 2021. High prevalence of infectious diseases and various ...

Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)

Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)

  • $ 800
  • Industry report
  • June 2017
  • by Koncept Analytics

HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body.HIV reduces the number of T-cells in the body and makes ...

POC Diagnostics Market Forecast 2017-2027

POC Diagnostics Market Forecast 2017-2027

  • $ 3247
  • Industry report
  • September 2017
  • by Visiongain

Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading CompaniesReport ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.